Viridian Therapeutics Inc

Viridian Therapeutics, Inc. operates as a biotechnology company. The Company specializes in developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications. Viridian Therapeutics serves customers in the United States.